24,000 Shares in HealthEquity, Inc. (NASDAQ:HQY) Acquired by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System acquired a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 24,000 shares of the company’s stock, valued at approximately $1,591,000.

Several other large investors have also recently modified their holdings of HQY. PNC Financial Services Group Inc. grew its position in HealthEquity by 31.8% during the 1st quarter. PNC Financial Services Group Inc. now owns 13,547 shares of the company’s stock worth $913,000 after purchasing an additional 3,266 shares during the last quarter. AlphaCrest Capital Management LLC purchased a new stake in HealthEquity during the 1st quarter worth approximately $234,000. Natixis Advisors L.P. purchased a new stake in HealthEquity during the 1st quarter worth approximately $932,000. Bank of Montreal Can grew its position in HealthEquity by 44.5% during the 1st quarter. Bank of Montreal Can now owns 8,218 shares of the company’s stock worth $553,000 after purchasing an additional 2,532 shares during the last quarter. Finally, Rhumbline Advisers grew its position in HealthEquity by 2.2% during the 1st quarter. Rhumbline Advisers now owns 231,307 shares of the company’s stock worth $15,599,000 after purchasing an additional 4,880 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

NASDAQ:HQY opened at $80.89 on Friday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 4.76 and a current ratio of 4.76. The company has a fifty day moving average of $81.08 and a two-hundred day moving average of $74.26. The stock has a market capitalization of $6.94 billion, a PE ratio of 126.39, a P/E/G ratio of 1.30 and a beta of 0.53. HealthEquity, Inc. has a fifty-two week low of $48.86 and a fifty-two week high of $84.49.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, March 19th. The company reported $0.50 earnings per share for the quarter, topping analysts’ consensus estimates of $0.42 by $0.08. The company had revenue of $262.39 million during the quarter, compared to analysts’ expectations of $258.56 million. HealthEquity had a net margin of 5.57% and a return on equity of 6.91%. As a group, research analysts forecast that HealthEquity, Inc. will post 2.12 earnings per share for the current fiscal year.

Insider Activity

In other news, EVP Delano Ladd sold 2,499 shares of the stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $80.00, for a total value of $199,920.00. Following the completion of the sale, the executive vice president now directly owns 49,996 shares in the company, valued at $3,999,680. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, EVP Delano Ladd sold 2,499 shares of the company’s stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $80.00, for a total value of $199,920.00. Following the completion of the sale, the executive vice president now owns 49,996 shares of the company’s stock, valued at $3,999,680. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Evelyn S. Dilsaver sold 32,500 shares of the company’s stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $79.29, for a total transaction of $2,576,925.00. Following the completion of the sale, the director now directly owns 32,123 shares of the company’s stock, valued at approximately $2,547,032.67. The disclosure for this sale can be found here. Insiders sold 71,322 shares of company stock worth $5,682,895 over the last three months. Insiders own 2.70% of the company’s stock.

Analyst Ratings Changes

Several analysts have weighed in on HQY shares. JPMorgan Chase & Co. boosted their target price on shares of HealthEquity from $86.00 to $108.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 2nd. Barrington Research reissued an “outperform” rating and set a $100.00 target price on shares of HealthEquity in a research report on Friday, March 22nd. Bank of America upped their price objective on shares of HealthEquity from $93.00 to $97.00 and gave the company a “buy” rating in a report on Wednesday, March 20th. Barclays upped their price objective on shares of HealthEquity from $84.00 to $104.00 and gave the company an “overweight” rating in a report on Friday, February 23rd. Finally, JMP Securities began coverage on shares of HealthEquity in a report on Thursday, April 4th. They issued a “mkt outperform” rating and a $101.00 price objective on the stock. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $96.17.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.